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Drosophila melanogaster Toll is the founding
member of an important family of pathogen-recogni-
tion receptors in humans, the Toll-like receptor (TLR)
family. In contrast, the prototypical receptor is a cyto-
kine-like receptor for Spa¨tzle (Spz) protein and plays
a dual role in both development and immunity. Here,
we present the crystal structure of the N-terminal
domain of the receptor that encompasses the first
201 amino acids at 2.4 A˚ resolution. To our knowl-
edge, the cysteine-rich cap adopts a novel fold
unique to Toll-1 orthologs in insects and that is not
critical for ligand binding. However, we observed
that an antibody directed against the first ten LRRs
blocks Spz signaling in a Drosophila cell-based
assay. Supplemented by point mutagenesis and
deletion analysis, our data suggests that the region
up to LRR 14 is involved in Spz binding. Comparison
withmammalian TLRs reconciles previous contradic-
tory findings about the mechanism of Toll activation.
INTRODUCTION
Over the past hundred years, the fruit fly Drosophila mela-
nogaster has been an extremely successful model organism
that has allowed the characterization of a number of key path-
ways in both insects and mammals. Genetic screens triggered
‘‘stunning’’ embryos (translated from ‘‘Toll’’ in German) with
defects in the dorsoventral axis (Anderson et al., 1985). It was
later discovered that the Toll gene was critical in the innate
immunity of adult flies (Lemaitre et al., 1996). Homologs of Toll
have been identified in mammals based on their conserved
architecture with leucine-rich repeat (LRR) ectodomains,
single-pass transmembrane domains, and intracellular signaling
domains (Medzhitov et al., 1997). The latter is shared by Toll and
the interleukin-1 receptor (TIR domain) (Gay and Keith, 1991).
Mammalian Toll counterparts, the Toll-like receptors (TLRs),
have a conserved role in immunity without any involvement in
embryonic development. TLRs are true pathogen-recognition
receptors that bind directly to a diverse repertoire of microbial
signature molecules, ranging from lipopolysaccharide (LPS) for
TLR4; lipopeptides for TLRs 2, 1, and 6; nucleic acids for TLRs
3, 7, 8, and 9; and flagella protein for TLR5 (Gay and Gangloff,Structure 21, 142007). In contrast, Toll is a cytokine-like receptor for an endoge-
nous protein Spa¨tzle (Spz) that is unique to insects. Spz is struc-
turally related to mammalian growth factors, such as the nerve
growth factor (NGF) (Hoffmann et al., 2008; Mizuguchi et al.,
1998). It is expressed as an inactive pro-protein that is targeted
by specific protease cascades during development and immu-
nity, respectively. Endoproteolytic processing of Spz triggers
a conformational change in its C-terminal active fragment of
106 amino acids (C-106) that engages the receptor and initiates
signaling (Arnot et al., 2010). A core set of adaptors, dMyD88,
Tube, and Pelle, constitute the immediate postreceptor mole-
cules. Intracellular signaling involves protein assemblies medi-
ated initially by the TIR domains of the receptor and dMyD88
and then via the Death domains (DD) of Tube and Pelle. The latter
is a kinase that triggers the phosphorylation of Cactus (IkB
homolog) and activation of the transcription factors Dorsal and
Dorsal-related Immunity Factor (DIF) (homologs of NF-kB), in
development and immunity, respectively.
The N-terminal extracellular domain (ECD) of Toll and TLRs is
responsible for the ligand binding. Signaling in turn is achieved
via ligand-induced dimerization followed by receptor clustering
with cell-specific signaling molecules. The versatile leucine-
rich repeat (LRR) motifs in the ECD provide key sites to fulfill
these functions. The LRR consensus is typically a short
sequence that consists of about 24 residues with leucine resi-
dues at conserved positions. Each repeat contributes one turn
to the coil that spans throughout the ECD. The conserved
leucines participate in the hydrophobic core, whereas the non-
conserved residues are surface-exposed and likely candidates
for molecular interactions. Toll possesses 21 predicted LRR
sequences segregated in two blocks capped by cysteine-rich
regions (Figure S1 available online). There are two types of
cysteine-rich regions at the N- (LRRNT) and the C terminus
(LRRCT) of each block. In Toll, the N-terminal block is involved
in ligand binding, whereas the C-terminal one mediates receptor
dimerization (Schneider et al., 1991; Weber et al., 2005).
Toll stands out compared to other members of the family with
regards to its dual role in development and immunity, its endog-
enous ligand, and also its heterogeneous stoichiometry (Gangl-
off et al., 2008; Weber et al., 2005). As for a growing number of
cytokine receptors, Toll has been found to form low-affinity
dimers with a dissociation constant of 2 mM in the absence of
ligand. In the presence of Spz C-106, it is predominantly found
in 2:2 complexes with a fraction of 1:1 receptor-ligand associa-
tions and trace amounts of 2:1 complexes. This heterogeneity
has been attributed to the negative cooperativity of the system3–153, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 143
Table 1. X-Ray Diffraction Data Collection and Refinement
Statistics
Native Derivative
Data Collection
Space group P212121 P43212
Cell parameters
a, b, c (A˚) 88.79, 93.28, 225.34 87.64, 87.64, 220.74
a, b, g () 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution (A˚) 29.9–2.41
(2.54–2.41)a
47.40–3.00
(3.16–3.00)a
No. observations 481,766 234,278
No. unique reflections 72,966 18,063
Rmerge (%)
b 0.056 (0.542)a 0.138 (0.653)a
I/s(I) 20.6 (3.0)a
Completeness (%) 99.3 (97.1)a 99.9 (100.0)a
Mean multiplicity 6.6 (6.0)a 13.0 (12.0)a
Refinement
Resolution (A˚) 29.9–2.41
No. reflections (total) 72,763
No. reflections (test) 3668
Rwork (%)
c 20.09
Rfree (%)
d 21.58
No. atoms 9,283
Protein 8,715
Heterogen atoms 245
Water molecules 323
Mean B (A˚2) 66.50
Rmsds
Bond lengths (A˚) 0.008
Bond angles () 0.97
aNumbers in parentheses refer to the highest resolution shell.
bRmerge =
P
hkl(
P
i(jI hkl,i- < I hkl > j))/Phkl,i < I hkl >, with I hkl,i the inten-
sity of an individual measurement of the reflection with Miller indices h, k,
and l, and < I hkl > the mean intensity of that reflection. Value calculated
for I > 3s(I).
cRwork =
P
hkl(jjFobshkljjFcalchkljj)/jFobshklj, where jFobshklj and
jFcalchklj are the observed and calculated structure factor amplitudes.
dRfree is calculated as Rwork with 5% reflections omitted from the refine-
ment process.
Figure 1. Overall Topology of the TollN6-VLR Hybrid
(A) View facing the concave surface of the leucine-rich fold. Glycans attached
to asparagine residues 80, 140, and 175 are depicted with light-blue spheres.
The Toll LRRNT cap is represented in marine, LRRs are in cyan, and the VLR
LRRCT cap is in gray.
(B) Left side view showing the curvature of the LRRs. Disulfide bonds are
shown as yellow sticks.
See also Figure S1.
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Toll LRRNT Cap Is Not Critical for Spa¨tzle Binding(Weber et al., 2005). Remarkably, the closest structural homolog
of C-106, NGF has also been described in different ratios with its
receptor p75NTR (Aurikko et al., 2005; He and Garcia, 2004).
Previously, we have solved the low-resolution structures of
Toll monomers and dimers in the presence and absence of
Spz C-106, respectively (Gangloff et al., 2008). In this study we
have engaged in truncating the receptor following the hybrid
LRR technology (Kim et al., 2007). This strategy proved success-
ful, and crystals that diffracted to 2.4 A˚ resolution were obtained
with a 201-residue-long N-terminal fragment. The crystal struc-
ture of the hybrid between Toll (residues 28–228) and variable
lymphocyte receptor (VLR) B.61 (residues 133–201) and its func-
tional and biochemical characterization are presented here. To
our knowledge, the N-terminal cap adopts a novel fold that is
unique to the subtype of Toll-1 receptors in insects. We show144 Structure 21, 143–153, January 8, 2013 ª2013 Elsevier Ltd All rigthat this region is not sufficient for Spz binding in contrast to
larger fragments.
RESULTS
Determination of the Molecular Structure of the
N-Terminal Domain of Toll
The full-length ECD failed to produce material suitable for X-ray
crystallography and so did the C-terminal deletion previously
characterized, Toll5B (Schneider et al., 1991; Weber et al.,
2005). A truncation encompassing the N-terminal domain up to
residue Leu 228 was generated according to the hybrid LRR
technology and referred to as TollN6-VLR (Kim et al., 2007).
This construct was chosen based on the human TLR4 one that
yielded structures in the presence and absence of Eritoran-
bound myeloid differentiation factor-2 (MD-2) (Kim et al., 2007).
The recombinant protein displayed an additional 4 kDa
compared to its predictedmolecular weight (31 kDa), suggesting
that it was modified with carbohydrates. The protein crystallized
in the orthorhombic space group P212121. Molecular replace-
ment with a variety of models and ensembles based on
structures of TLRs, glycoprotein Ib a, the Nogo receptor, and
the variable lymphocyte receptor (VLR) failed to provide a solu-
tion. Experimental phases arose from single-wavelength anom-
alous dispersion using 5-amino-2,4,6-triiodoisophthalic acid
(I3C) (Beck et al., 2008). The native structure was determined
to 2.4 A˚ by molecular replacement using the partial model and
refined to an Rwork of 20.1% (Rfree of 21.6%) (Table 1). The
I3C-bound structure refined at 3.0 A˚ is described in more detail
elsewhere (M.G., A. Moreno, and N.J.G., unpublished data).
Overall Architecture and Crystal Packing
The crystal structure of TollN6-VLR adopts an arc-shape typical
of the leucine-rich repeat (LRR) fold (Figure 1). It is made of anhts reserved
Figure 2. Crystal Packing
(A) Asymmetric unit with four molecules of native
TollN6-VLR and twomalonate ions (MLI). Chain A in
green, B in cyan, C in magenta, and D in yellow
with the VLR portion in a paler color.
(B) View tilted by 90 showing the pseudo 2-fold
axis, by which the A-C and B-D pairs are related to
each other.
(C) Molecular surfaces in the asymmetric unit. The
VLR caps mediate most of the crystal contacts. A
large glycan structure protrudes from one of the
chains and is depicted in magenta sticks.
(D) Close-up view on the complex glycan structure
bound to Asn 140.
See also Table S1 and Figure S3.
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Toll LRRNT Cap Is Not Critical for Spa¨tzle BindingN-terminal capping structure (Ser 28–Leu 94) also known as
LRRNT and contains three cystines, followed by five LRRs orig-
inating entirely from the Toll receptor and a hybrid one (LRR6)
with the junction between Toll and VLR at Leu 228, which is
the last Leu in the LRR consensus sequence LxxLxL/xxN, where
L stands for Leucine, N for Asparagine, and x for any amino acids
(Figure S1). The sixth LRR is tagged along by a cysteine-rich
C-terminal capping structure (LRRCT) of VLR B.61. This addi-
tional structure is designed to protect the hydrophobic core of
the last LRR from solvent exposure. In addition, the structure
of this region has helped in other studies to solve the phase
problem by molecular replacement with one copy of the mole-
cule in the smallest repeating building block of the crystal, the
asymmetric unit (Kim et al., 2007; Yoon et al., 2012).
In contrast, the asymmetric unit of native TollN6-VLR crystals
contains four molecules (Figure 2). Molecules labeled A-C
and B-D form pairs that relate to each other by a pseudo
2-fold axis and numerous VLR-mediated contacts. They are
head-to-head ‘‘spooning pairs’’ tilted by 40 compared to
each other. The tetrameric stoichiometry was detected
in solution by dynamic light scattering (DLS) measurements,
giving a diameter of 12.7 nm (Z-average size using the cumulant
method) and a polydispersion index of about 0.1. In the
crystalline form, the size of the four molecules is approximately
45 3 80 3 100 A˚3, in contrast to the sizes of protomers
25 3 30 3 80 A˚3 and ‘‘spooning’’ pairs 40 3 55 3 80 A˚3. The
superposition of the dimers displays a root-mean-square
deviation (rmsd) of 0.75 A˚ over 3,942 atoms. The rmsds of super-
posed protomers are around 0.5 A˚ between the different mole-
cules. The highest structural divergence is found in the
N-terminal loops, in particular at residues Ser 38–Cys 43 and
Pro 57–Pro 63.Structure 21, 143–153, January 8, 2013Structural Features of the
Extended N-Terminal Cap of Toll
Searches using DALI (Holm and Rose-
nstro¨m, 2010) confirmed that the Toll
LRRNT adopts a new fold that is shared
by Toll-1 paralogues in insects (Figure 3).
Toll-like receptors (TLRs) in mammals
and Toll orthologs in D. melanogaster do
not possess this feature (Figure S2). In
the crystal structure the N-terminal
amphipathic alpha helix (Arg31–Asp40)that is solvent exposed consists of mostly negatively charged
residues (Asp32, Glu36, Asp40) and is tethered to the first
beta-strand by a disulfide bond (Cys34-Cys45). The extremities
of the helix are not well resolved in electron density and have
been refined with missing side chains and/or high B factors
that reflect the flexibility of this region. Next, the cap forms
a four-stranded antiparallel beta-sheet linked by two short turns
(two-residue turns) and a seven-residue long loop. This loop
separating the duplicated hairpin structures, is located between
the second and the third strand of the cap, and adopts different
conformations in the different molecules of the a.u. Two addi-
tional disulfide bonds stabilize the LRRNT cap in Toll. The cova-
lent bond between Cys43-Cys56 pins down the two first strands,
and this structural organization is shared by the LRRNT caps of
other extracytoplasmic LRR proteins, such as TLR4 (Kim et al.,
2007; Park et al., 2009), glycoprotein Ib a (Huizinga et al.,
2002; Uff et al., 2002), Nogo receptor (Barton et al., 2003; He
et al., 2003), CD14 (Kim et al., 2005), but is not found in the
shorter TLR1 LRRNT (Jin et al., 2007), for instance (Figure 3).
The second disulfide bridge between Cys79-Cys107 anchors
the fourth strand of the cap to the first leucine-rich repeat
(LRR1). This weak bond undergoes radiation damage as sug-
gested by the jFojjFcj electron density.
Conformational Diversity of the N-Terminal Toll LRRs
Toll LRRs appear irregular in length (between 28 in LRR1 and 23
residues in LRR4) and in secondary structure content (presence
of alpha-helices on the convex side in LRR1 and LRR2). The
region spanning residues 92 to 359 was nevertheless annotated
as a LRR region, but LRR4 was recognized as the first repeat in
UniProt (Toll accession code P08953). A parallel beta-sheet
defines the concave side and is formed by five-residue-longª2013 Elsevier Ltd All rights reserved 145
Figure 3. TheN-Terminal Cap of Toll Adopts
a Unique Fold
(A) Sequence alignment of the N-terminal domain
of Toll-1 receptor paralogues in insects.
Drosophila melanogaster Toll (Dm-1); Drosophila
sechellia (Ds-1); Aedes aegypti (Aa-1); Anopheles
gambiae (Ag-1); Bombus terrestris (Bt-1); and
Tribolium castaneum (Tc-1).
(B–G) N-terminal domains of extracellular LRR
proteins. (B) Toll, (C) TLR4, (D) glycoprotein Ib a,
(E) Nogo receptor, (F) TLR1, and (G) CD14. LRR
proteins are shown in the same orientation to
highlight the structural diversity of their LRRNTs
(in blue). LRRs are represented in cyan, and
disulfide bonds are in yellow.
See also Figure S2.
Structure
Toll LRRNT Cap Is Not Critical for Spa¨tzle Bindingbeta-strands in LRR1–4 and three-residue-long in LRR5 and
LRR6. An asparagine ladder usually found in position 13 in the
consensus sequence is replaced by Cys, Ser, Thr, or Ala
throughout LRR1–4, respectively (Figure S1). Furthermore,
a conserved phenylalanine residue features in LRR4, LRR5 and
is predicted to occur throughout ten further repeats in the first
block of LRRs in Toll to form a hydrophobic spine (Figure S2).
The ribbon traces of the repeats observed in the crystal structure
go from eight-shaped to flat (Figure 4). The lack of planarity in the
first repeats explains why shorter truncations did not express
(data not shown). Such fusions would expose hydrophobic
patches at the junction between Toll and the flat LRRCT from146 Structure 21, 143–153, January 8, 2013 ª2013 Elsevier Ltd All rights reservedthe VLR even though the prediction of
the repeat was correct in terms of primary
sequence. This is a perfect illustration of
the structural diversity of LRRs. They are
easily recognizable in sequence but diffi-
cult to predict in three dimensions.
Glycans Participate in the Crystal
Packing
The Toll-VLR construct contains three
glycosylation sites located on Toll at Asn
80, 140, and 175 as predicted by the
consensus Asn-X-Ser or -Thr sequon
with X (any amino acid other than a Pro)
(Table S1). Although the first-two glyco-
sylation sites are located on the right flank
of the molecule, that is, Asn 80 lies at the
end of the fourth strand of the extended
LRRNT cap and Asn 140 occurs in
LRR2, the Asn 175 residue is found on
the left flank in LRR4. Interestingly, the
flanks of Toll were overall free of crystal
contacts, because of the presence of
sugars. The innermost N-acetyl glucos-
amine (NAG) attached to the Asn residue
by a beta (1-4) link was more often
observed than subsequent residues,
probably because of its lesser degree of
flexibility. Carbohydrates could not be
added to Asn 140 and Asn 175 in somemolecules because of the lack of clear electron density. Mass
spectrometry analysis of the Asn 175 confirmed the presence
of glycans albeit partially occupied (data not shown). It is,
however, not clear if glycosylation promoted crystal packing or
contributed to the poor quality of the crystals, as no crystals
were obtained with enzymatically deglycosylated protein.
Carbohydrates participate in two types of contacts in the
crystal structure; some are involved in protein-sugar interactions
and others stack up to form a pattern reminiscent of a ‘‘sugar
zipper’’ (Figure 2), a term first quoted by Dorothe Spillmann in
reference to cellular recognition (Spillmann, 1994). This occurs
on the left flank of each pair and involves the Asn 140 glycan of
Figure 4. Conformational Diversity of the
N-Terminal Leucine-Rich Repeats of Toll
(A–F) Each Toll LRR is represented as a cross-
section in a planar and a side view at 90. (F) The
hybrid construction in LRR6 is flat, allowing
the complete burial of hydrophobic residues in the
contiguous LRRs.
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Toll LRRNT Cap Is Not Critical for Spa¨tzle Bindingchains A or D and the Asn 80 of chains C or B. Such interactions
are in stark contrast to the crystal packing of the human counter-
part TLR427-228-VLR128-199 (Kim et al., 2007). This structure was
determined in the same space group, as native TollN6-VLR but
with only one molecule per asymmetric unit. As a consequence,
the packing is much tighter for the latter with a solvent content
of about 40% as opposed to 60% for TollN6-VLR. Despite the
remote homology and similar hybrid construction, the presence
of glycan interdigitation is only observed for Toll-VLR.
Moreover, the glycan structure bound to Asn 140 in chain C is
remarkable for two reasons. First, it makes extensive contacts
with amino acids of a symmetry-related chain noted C* at the
left flank of the VLR fusion. It is wedged between the two VLR
domains, where it forms multiple polar interactions. And,
second, an additional fucose residue (Fuc 505 in chain C) is
linked by a beta (1-3) bond unique to plants and some insects
(Tomiya et al., 2004).
Protein-Protein Contacts
To detect functional areas, we decided to more closely inspect
crystal contacts mediated by proteins (Figure 5). There are three
types of contacts in the asymmetric unit; two of them involve
VLR regions. These interfaces have a surface area of approxi-
mately 1,110 A˚2 and530 A˚2. Contactsmediatedby theVLR region
arenot of biological relevance to the functionof Toll andwill not be
considered further. The third type of interface occurs between
the concave and the convex sides of the A-C and B-D pairs. As
it involves the Toll portion of the molecule, it may either reflect
the ligand binding or the dimerization mode of the receptor. This
interface covers a surface area of 577 and 618 A˚2 in each pair,
respectively. Eight hydrogen bonds stabilize the interface located
between the LRRNT and the first 2 LRRs. Such a surface area
would be too small to mediate stable ligand binding or receptor
dimerization on its own but may be part of a lager network of
interactions that have been truncated in the Toll-VLR construct.
In order to determine if such associations are possible in the
context of the full-length ectodomain, we overlaid the models
of the entire ECD on the truncations. This was achieved
by improving our existing ECDmodel by using the newly charac-
terized N terminus as a template (Gangloff et al., 2008). TheStructure 21, 143–153, January 8, 2013Supplemental Experimental Procedures
give details of the generation of themodel
and its structural alignment with the
TollN6-VLR crystal structure (Figure S3).
We found a number of steric clashes
within the A-C and B-D pairs. Glycans
that spread throughout the ECD restrict
contacts on the flanks and the convex
side. The concave side is inaccessible
because of glycans on LRRs 7, 11, 16,18, and 19 (Table S1). More importantly, the translational shift
that the ECDs undergo in the concave-convex pause is incom-
patible with the transmembrane location of the receptor.
In contrast, A and B chains interact at the right flank of LRR6 in
a symmetrical way that leaves their C-terminal ends about 220 A˚
apart. Asymmetric interactions occur between molecules A and
D, and also between B and C, at the right flank of LRR2-6 of the
latter with LRR7-11 of the former. None of these arrangements is
suitable for signaling to the intracellular compartment as the TIR
domains are separated by about 200 A˚ and may illustrate poten-
tial quaternary arrangements of Toll in its inactive state.
Binding Mode of Crystallization Agents
The binding mode of small molecules from the crystallization
buffer is analyzed to reveal further areas of potential functional
importance. Malonate ions (MLI) and I3C were fitted in the elec-
tron density of the native and derivative structures (Figure 6). The
contacts that these small molecules make with the protein are
listed in Table S2. One malonate is located at the pseudo
2-fold axis in a position where it forms hydrogen bonds with
Ser 235 and Gln 211 and van der Waals contacts with Val 236
and Pro 237 in both VLR domains of chains A and B. A second
malonate nests against the right flank of chains B and C, in the
VLR portion of the hybrid molecules, where it makes polar
contacts with the hydroxyl of Ser 287 and the carbonyl of its
peptide bond, as well as one of the preceding amino acids, Gly
286. It also makes van der Waals contacts with the cystine Cys
259- Cys 284 of VLR LRRCT. Several molecules of water bridge
the ion to residues from the Toll portion of the hybrid on the right
flank of LRR5 and LRR6. More importantly, the amine moiety of
Lys 208 in LRR5 is less than 4 A˚ away from one of its carboxyl-
ates, and the Lys side chain makes van der Waals contacts
with it. I3C, the molecule used for phasing, binds at the concave
side and interacts with residues from each LRR. It forms a strong
hydrogen bond at 3 A˚ with Arg 154.
TollN6-VLR Does Not Form a Stable Complex with Spz
C-106
Next, we sought to characterize the complex between Toll and
its protein ligand Spz C-106. Whereas TollN6-VLR is an apparentª2013 Elsevier Ltd All rights reserved 147
Figure 5. Protein-Protein Contacts
(A–D) Areas of crystal contact are indicated on the molecular surfaces of
TollN6-VLR in different views. (A) View facing the concave side, (B) right flank,
(C) left flank, and (D) convex side. The first column delineates the structural
areas in TollN6-VLR with LRRNT in dark blue, LRRs in marine, VLR-LRRCT in
light cyan, and glycans in light blue. The second column shows the molecular
surface of chain B, and the third is chain D. Contacts are color-coded ac-
cording to the identity of the molecule that mediates them: chain A is in green,
B in cyan, C in magenta, and D in yellow. Residues that have been targeted by
site-directed mutagenesis are highlighted in red. See also Figure S3.
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Toll LRRNT Cap Is Not Critical for Spa¨tzle Bindingmonomer of 40 kDa, upon combining the truncated receptor
construct with C-106 in equimolar concentrations, there is no
left shift in the chromatogram (Figure 7A). In order to confirm
the activity of the ligand, the same preparation of C-106 was
used to yield full-length Toll ECD-Spz complexes that elute as
280 kDa molecular species, which corresponds to a 2:2 molec-
ular ratio (data not shown). In the presence of the truncation en-
compassing Toll residues 28–228, the mixture with C-106 elutes
instead in between the elution volumes of the individual proteins.
This behavior suggests that either the two proteins do not
interact, that they interact with a dramatic change in overall
shape, or that they assemble into a transient complex that is
not resolved by this technique.
In order to further investigate if C-106 binds TollN6-VLR, we
carried out analytical ultracentrifugation (AUC), which can detect148 Structure 21, 143–153, January 8, 2013 ª2013 Elsevier Ltd All rigchanges in shape and stoichiometry in a more sensitive way as
these parameters are reflected by differences in the sedimenta-
tion coefficient (Figure 7B). The sedimentation velocity method
was applied on both proteins in isolation and mixed together in
equimolar amounts to determine if a receptor-ligand complex
can form in solution. Samples of concentrations between
10.5 mM and 17.6 mM were analyzed, and their sedimentation
rates were calculated. The quality of the data is excellent, and
the local root-mean-square deviation for each fit was below
0.006. Individually, C-106 and TollN6-VLR have sedimentation
coefficients of 2.24 S and 2.69 S, respectively. In contrast to
size-exclusion chromatography, AUC detected molecular
species with a very broad sedimentation rate peaking at 2.54 S
and ranging approximately from 2 S to 3 S. The absence of right
shift with the combined proteins suggests that the complex
formed with the truncated receptor is unstable.
Functional Sites Are Located in the N-Terminal LRRs but
Not in the Cap
Selected residues in the Toll ECD were subjected to site-
directed mutagenesis and tested in a cell-based signaling assay
to assess their function. The cysteine-rich capping structure has
been shown to play a critical role in ligand binding for a number of
extracellular LRR receptor, such as mammalian TLRs and the
receptor of von Willebrand factor, glycoprotein Ib a (Huizinga
et al., 2002). In particular, the TLR4 single mutants, Cys 29 Ala
and Cys 40 Ala, and the double mutant Cys 29,40 Ala, were
neither coprecipitated with its coreceptor MD-2 nor expressed
on the cell surface and failed to transmit LPS signaling (Nishitani
et al., 2006). In order to check the role of cysteine residues in Toll,
we carried out site-directed mutagenesis on Cys 34, Cys 43, and
Cys 45 that form two disulfide bonds Cys 34-Cys 45 and
Cys 43-Cys 56. The mutations predicted to be destabilizing
(Table S3) were introduced in the Toll-TLR4 chimera that
comprises the ECD and the transmembrane region of Toll linked
to the TIR domain of human TLR4 (Weber et al., 2005). This
construct was found to mediate signaling of an NF-kB reporter
gene in response to cleaved Spz in transfected human embry-
onic kidney HEK293ET cells (Figure 8). The fact that Spz
manages to signal in the context of the Toll-TLR4 chimera
suggests that themechanism of signal transduction is conserved
in Toll and TLR4. The signal was decreased by about 10% upon
introduction of the single and double mutations, which implies
that the integrity of the cysteine-rich capping structure affects
Toll activation only mildly in contrast to TLR4. Another mutation
in the cap involving a negative to a positive charge reversal Glu
36 Arg did not impede signaling either (data not shown).
Next, we chose residues located in crystal contacts and
glycan-free areas. We investigated if the buffer binding sites
observed in the crystal structure are functionally relevant by
carrying out site-directed mutagenesis on Arg 154 located on
the convex side of LRR3 and on Lys 208 located on the right
flank of LRR5 (Figure 6). The positively charged Arg 154 was
substituted by alanine. The mutation was introduced in the
Toll-TLR4 chimera and retained wild-type signaling capacities.
The charge reversal mutation Lys 208 Glu led to a decrease in
signaling by one-fourth compared to the wild-type receptor.
This suggests that the malonate-binding site is functionally
important. Another site was chosen approximately in the middlehts reserved
Figure 6. Binding Mode of Crystallization
Molecules
(A and B) TollN6-VLR binds malonate ions (MLI) in
the native structure, and (C) I3C molecules in the
derivative. (A) MLI bound at the pseudo 2-fold
axis; (B) MLI bound to chain B in blue and C in
magenta. (C) I3C binds to the concave side and
interacts with residues of the beta-sheet of
chain A and the left flank of the chain B. See also
Table S2.
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Toll LRRNT Cap Is Not Critical for Spa¨tzle Bindingof the glycan-bare convex side of Toll ECD. Themutation Arg 432
Ala located on LRR14 decreased the signal by one-third. Inter-
estingly, this residue is located 60 A˚ away from the previous
one and sits across the curved solenoid surface, which increases
even further its distance. Spz forms a covalent dimer of approx-
imately 25 3 55 3 60 A˚3 that cannot reach across both sites
unless it does so in the context of a Toll dimer in which it may
contact LRR5 on the right flank of one receptor molecule and
LRR14 on the convex side of the second one.
An Antibody that Binds the First Ten LRRs Prevents
Signaling
To further investigate the importance of the N-terminal region of
Toll, assays were performed using a Drosophila S2 cell line that
was stably transfected with a luciferase reporter under the
control of the drosomycin promoter, as previously described
(Arnot et al., 2010). Using these cells, maximum activation of
the reporter is achieved at 10 nMC-106; thus, this concentration
was used for the assay. A 4-fold molar excess of a polyclonal
anti-Toll antibody directed against Toll residues 31–330 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) was first added to
the cells (this amount was chosen to ensure that the excess of
antibody would saturate all binding sites) and following a 2 hr
incubation, cleaved Spz was then added to the cells in order to
test whether or not signaling would occur (Figure 9A). The anti-
body completely blocked signaling by either blocking access
of Spz to the receptor or by preventing Toll dimerization. As
the antibody is directed against the N terminus of Toll up to
LRR10, it was important to establish whether this area is able
to promote receptor dimerization. This was achieved by charac-
terizing a larger Toll truncation that encompasses the N-terminal
region up to Leu 398 in LRR13. This construct is of similar length
to the one that was used in the crystal structure of flagellin-
bound TLR5 (Yoon et al., 2012). We found that the TollN13-VLR
construct remained monomeric in solution and formed a 1:1
complex in the presence Spz C-106 (Figure 9B). Given that the
antibody recognizes the receptor in a region unable to mediate
dimerization, we conclude that signaling is prevented by compe-
tition with ligand binding within the first ten LRRs.
DISCUSSION
We present the crystal structure of the N-terminal domain of
D. melanogaster Toll and show that it adopts a fold unique to
Toll-1 orthologs in insects. There are nine Toll paralogues in
D. melanogaster and six Spz isoforms. Functional Toll-Spz pairs
other than Toll-1Spz-1 have not been characterized yet. Toll
receptors in D. melanogaster belong to three groups based onStructure 21, 14the architecture of their ECDs (Figure S4). The first group is the
largest and includes six receptors 1, 2, 5, 6, and 7, which contain
two blocks of LRRs in their ECDs. In contrast, the second group
contains Toll-9 that has a single domain of LRRs. Earlier phyloge-
netic analysis reveal that this receptor and the mammalian TLRs
share a common ancestor as they are more closely related to
each other than to other insect receptors (Bilak et al., 2003;
Gangloff et al., 2003). Finally, the third group of Toll-3 and Toll-
4 differs considerably from Toll-1 and TLRs with several shorter
LRR domains and no secretion signal. Assuming that Toll-Spz
pairs are unique, we speculate that the six Spz isoforms bind
the six members of the first group of Toll receptors. None of
them share the duplicated LRRNT cap of the prototypical Toll
receptor, which our study revealed not to be critically involved
in Spz recognition. Additionally, Toll-7 has recently been shown
to respond to vesicular stomatitis virus (VSV) glycoprotein G
(Nakamoto et al., 2012). In contrast to Toll-1 that exclusively
binds Spz-1 (Weber et al., 2003), it is conceivable that Toll-7
might be as promiscuous as mammalian TLR4, which is not
only the receptor for LPS but also for VSV (Georgel et al.,
2007) and a range of endogenous and exogenous molecules.
As the structural basis for Toll andSpz interaction is still elusive,
we used receptor truncations, blocking antibody and site-
directed mutagenesis to gain further insight. Schneider and
collaborators inferred that Toll truncations encompassing at least
the first 463 residues of the Toll ectodomain were sufficient for
C-106 binding (Schneider et al., 1991). The ethylmethane sulfo-
nate-induced mutation Toll84c (Gln 464 STOP) is a gain-of-
function mutant with ventralized phenotype. This effect required
the presence of a wild-type Toll protein and upstream genes to
exert their ventralizing effect. In the absence of the full-length
receptor the truncation produced entirely dorsalized embryos
as did knockout Toll - embryos. Receptor molecules deleted of
their transmembrane and cytoplasmic regions are thought to
diffuse the activated Spz ligand to more dorsal positions, where
it exchanges with and activates the wild-type receptor. This
causes the otherwise spatially restricted Spz signal to be elicited
inall parts of theembryo, thus triggeringall cells todevelopventral
cell fates. Toll residues 28–463 encompassing the first 15
LRRs could not be produced in sufficient amounts for structural
characterization. The present study narrows the area required
for ligand binding down to the first 13 LRRs with the character-
ization of a VLR construct containing residues 28–397. An anti-
body that binds the first ten LRRs blocks Toll signaling, which
suggests that access to this area is critical for Spz binding.
Based on the effect of the two mutations located in LRR5 and
LRR14 of Toll (Lys 208 Glu and Arg 432 Ala, respectively), we
propose a model for Spz C-106 binding in which the ligand3–153, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 149
Figure 7. Spa¨tzle Does Not Form a Stable Complex with TollN6-VLR
(A) Size-exclusion profiles. Processed Spz C-106 and TollN6-VLR elute in very similar volumes during gel-filtration.
(B) Analytical ultracentrifugation profiles.
(C–E) Fit and residuals after fitting to a c(s) model in SEDFIT and the distribution of sedimentation coefficients are shown for (C) Spz C-106 at 422 mg.ml1
(17.6 mM), (D) TollN6-VLR at 377 mg.ml1 (10.5 mM), and (E) TollN6-VLR and C-106 in equimolar amounts (940 mg.ml1).
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Toll LRRNT Cap Is Not Critical for Spa¨tzle Bindingpromotes receptor binding and crosslinking of a second
receptor chain into a ligand-induced receptor dimer, which
differs from the dimers found in the absence of ligand. The latter
are thought to keep the juxtamembranes sufficiently apart to
prevent productive TIR domain dimerization and recruitment
of the intracellular signaling machinery. Our revised model
suggests that Spz binds across the right flank and convex sides
of two Toll ECDs reminiscent of protein-binding TLRs (Park et al.,
2009; Yoon et al., 2012). A ligand-independent C-terminal dimer-
ization region is located in the second half of the ECD as sug-
gested by the characterization of a deletion product starting at
Asp 458 that forms constitutive dimers (Weber et al., 2005).
This establishes crudely the boundary between the N-terminal
ligand binding domain and the C-terminal dimerization region
at LRR14. Further work is clearly necessary to get a full picture.
The determination of the crystal structure of the Toll-Spz
complex will be aided by the data presented here.
EXPERIMENTAL PROCEDURES
Cell Culture
Sf9 cells were used for baculovirus generation and protein expression.
The cells were grown at 28C in a suspension culture using Sf-900 II SFM150 Structure 21, 143–153, January 8, 2013 ª2013 Elsevier Ltd All rig(Invitrogen, Carlsbad, CA, USA) supplemented with 0.1% pluronic acid
(Sigma-Aldrich, St. Louis, MO, USA). A stable Drosophila cell line (648-1B6)
expressing luciferase under the control of the drosomycin promoter was
established from S2 cells (Invitrogen) and was a kind gift from Jean-Luc Imler
(LeMosy et al., 2001). These cells were grown at 28C in Express Five
SFM (Invitrogen), supplemented with 2 mM L-glutamine, 1% penicillin/
streptomycin, and 0.5 mM puromycin. HEK293ET (human embryonic kidney
293 EBNA-T) cells were grown at 37C (5% CO2, 100% humidity) in
Dulbecco’s modified Eagle’s medium (Invitrogen), supplemented with 10%
fetal calf serum (Invitrogen) and 2 mM L-glutamine.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed using the QuikChange II kit (Strata-
gene, LaJolla, CA, USA). The primers are listed in Table S1. The mutagenized
insert were DNA-sequenced and then recloned into fresh pcDNA3.1(+) and
pFastBac-1 backbones as appropriate. Mutations did not affect protein ex-
pression levels as assessed by transient transfection of HEK293 cells followed
by western blot detection of the receptor and GAPDH as a loading control.
Luciferase Assay
S2 cells were placed into 96-well plates and stimulated overnight by the
addition of purified recombinant Spa¨tzle to the culture medium. Cells were
lysed using Passive Lysis buffer (Promega, Madison, WI, USA), and the activity
measured using a GloMax luminometer (Promega) immediately after the addi-
tion of the D-Luciferin substrate (Biosynth, Itasca, IL, USA). All assays were
performed three times in triplicate.hts reserved
Figure 8. Site-Directed Mutagenesis Confirms that Toll LRRNT Is
Not Critical for Signaling
HEK293ET cells were transfected with a Toll -TLR4 chimera and a NF-kB
luciferase reporter. Luciferase production was measured 24 hr after Spz
stimulation at a concentration of 10 nM. Data shown represents fold induction
compared with stimulation with media only. Data are represented as means ±
SEM. See also Table S3.
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Toll-VLR constructs encompassing Toll residues 1–228 and 1–397, respec-
tively, were generated as fusions with residues Asn 133–Thr 201 of hagfish
VLR B.61 by PCR. Toll truncations carried a 50-BamHI and a 30-NheI restriction
site. The LRRCT of VLR B6.1 was generated with a 50-NheI and a 30-AgeI
cloning site. The Fc domain of human IgG1 was amplified with a 50-AgeI
site, followed by a TEV cleavage site and 30-NotI site. Primers are listed in
Table S4. The Toll, VLR, and Fc fragments were digested with the correspond-
ing restriction enzymes. The three products were then ligated to form a single
Toll-VLR-Fc insert that was introduced into the BamHI and NotI sites of the
pFastBac-1 transposition vector (Bac-to-Bac; Invitrogen).
Protein Expression and Purification
Fc-tagged Toll N-terminal trunactions and His-tagged Spa¨tzle were produced
in a baculovirus expression system. The procedure for Spz preparation has
been described elsewhere (Gangloff et al., 2008). Toll-VLR constructs were ex-
pressed in Sf9 insect cells (Invitrogen). The supernatant was collected by
centrifugation 3 days after infection and concentrated using the CentramateStructure 21, 14tangential flow filtration system (Pall Filtron, VWR, Radnor, PA, USA). It was
loaded onto HiTrap protein A HP column (GE Healthcare, Waukesha, WI,
USA). Purified protein was eluted in 0.1 M sodium citrate (pH 3.0). The Fc
fusion was cleaved with TEV protease (Kapust et al., 2001). The digestion
products were separated by protein A affinity chromatography. Toll-VLR
constructs were further purified by size-exclusion chromatography in
100 mM NaCl and 20 mM Tris-HCl (pH 7.0).
Sedimentation Velocity Analytical Ultracentrifugation
All analytical ultracentrifugation experiments were performed on an Optima
XL-A/I (Beckman Coulter, Brea, CA, USA) centrifuge equipped with a four-
hole titanium rotor, double-sector centerpieces, and an interference optical
system for data acquisition. Sedimentation velocity runs were performed at
45,000 rpm with 3 min intervals between scans for a total of 190 scans at
20C. The sample volume was 400 ml. Data were analyzed using Sedfit
software (Schuck, 2000). The partial specific volumes, buffer density, and
viscosity were estimated using SEDNTERP software (Laue et al., 1992).
Dynamic Light Scattering Characterization
Dynamic light scattering (DLS) was performed using a Zetasizer Nano-S
instrument (Malvern Instruments, Malvern, Worcestershire, UK). Protein
samples in 100mMNaCl and 50mMTris-HCl (pH 7.0) buffer at an approximate
concentration of 200 mg.ml1 were centrifuged for 5 min at 13,000 g to remove
any aggregates. Aliquots of 40 ml were then loaded into disposable solvent-
resistant micro cuvettes (Malvern), followed by ten DLS measurements, which
were averaged to determine the diameter and polydispersion index of the
proteins in solution.
Crystallization of Toll-VLR
Crystals were obtained with the counterdiffusion method in agarose gels
(M.G., A. Moreno, and N.J.G., unpublished data). Briefly, 10 ml protein at
23 mg/ml was mixed with 10 ml agarose 0.6%, boiled for 1 min, and cooled
to about 40C before use. A volume of 8 ml protein mixture was introduced
in capillary tubes of internal diameter 0.3 mm and length 80 mm (Capillary
Tube Supplies, Withiel Bodmin, Cornwall, UK). It solidified within a few
minutes, upon which 20 ml sodium malonate 2.4 M (pH 7.0) was added on
top of the gel. The capillary was sealed on both ends using plasticine and
nail polish. Two weeks later, the precipitant solution was replaced with 10 ml
sodium malonate 3.4 M (pH 7.0) and allowed to diffuse for another couple of
weeks before harvesting the crystals. The crystal were washed in the already
cryoprotecting precipitant solution and mounted in 20 micron nylon cryoloops
(Hampton Research, Aliso Viejo, CA, USA) before being immersed in liquid
nitrogen for storage and diffraction. Native crystals belong to the space group
P212121 with cell parameters a = 88.79 A˚, b = 93.28 A˚, c = 225.34 A˚, a = b =
g = 90 (four molecules in the asymmetric unit, 62% solvent).
Heavy-Metal Derivatization
The counterdiffusion method was used for cocrystallization of TollN6-VLR and
5-amino-2,4,6-triiodoisophthalic acid (I3C) in 0.15 M I3C, 2.89 M sodiumFigure 9. An Antibody that Recognizes the
First Ten LRRs of Toll Blocks Spz Signaling
(A) The anti-Toll antibody was added to a culture of
S2 cells expressing Toll endogenously and which
have been stably transformed with a luciferase
reporter gene under a drosomycin promoter.
Following a 2 hr incubation, 10 nM of cleaved Spz
was added to the cells to test for activation and
signaling. Controls included glycerol alone, as well
as glycerol plus C-106, to ensure that glycerol
played no part in the stimulation (when acting as
a cryopreservant in the antibody solution), either
by activating or inhibiting it. Data is displayed as
fold induction compared to media control. Data
are represented as means ± SEM.
(B) Gel-filtration chromatography revealing that
TollN13-VLR is monomeric and binds Spz C106 in
a 1:1 complex.
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Toll LRRNT Cap Is Not Critical for Spa¨tzle Bindingmalonate (pH 7.0) (M.G., A. Moreno, and N.J.G., unpublished data). After an
initial diffusion period of two weeks, the precipitant solution was replaced
with 20 ml fresh I3C solution and allowed to equilibrate for another couple of
weeks. The anomalous signal of the bound iodines was exploited for phase
determination using the single anomalous dispersion (SAD) method. Derivative
crystals belong to the space groupP43212with cell parameters a = b = 87.64 A˚,
c = 220.74 A˚, a = b = g = 90 (two molecules in the asymmetric unit, 59%
solvent).
Data Collection, Phase Determination, and Model Refinement
The structure of TollN6-VLR was determined in two steps. The best SAD data
set was collected at a resolution of 3.0 A˚ at beamline ID23 of the European
Synchrotron Radiation Facility (ESRF, Grenoble, France). Oscillation images
were integrated, and reflection intensities were merged and scaled using the
XDS package (Kabsch, 2010). An electron density examination in Coot (Emsley
and Cowtan, 2004) confirmed the hand of the tetragonal space group and
allowed manual building of 85% of the molecular model. The partial model
was then used for molecular replacement in the 2.4 A˚ resolution native
orthorhombic data set. The final model was obtained after numerous rounds
of refinement in Buster (Blanc et al., 2004) and manual rebuilding in Coot.
Both 2jFoj-jFcj and jFoj-jFcj electron density maps were used in model
building. TLS refinement was used with one group per chain. A total of 333
water molecules were built that were within hydrogen bonding distance to
the protein. The structure was assessed for correctness and validated using
Molprobity (Chen et al., 2010).
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